Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Daily ear vagus‑nerve stimulation to reduce TMD jaw and facial pain

Official title: Evaluating Noninvasive Brain Stimulation for TMD Pain: A Feasibility Study

Run by University of Minnesota · NCT07517172 · Data updated 2026-11-12

This will test whether daily, at‑home gentle electrical stimulation of the ear's vagus nerve can reduce chronic jaw and facial pain in adults with temporomandibular disorder (TMD).

More Temporomandibular Disorder trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment40 (estimated)
SponsorUniversity of Minnesota
Academic / other
Locations1 site (Minneapolis, Minnesota)
StatusRecruiting
StartedMay 20, 2026
Main results expectedSeptember 30, 2027
Study endsSeptember 30, 2027
Registry record updatedMay 29, 2026
Trial IDNCT07517172 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 with a DC‑TMD diagnosis, at least 3 months of pain scoring ≥4/10, who can read English, have a smartphone or computer, and are willing to self‑administer daily tAN at home are ideal candidates.

Probably not a fit

People with certain neurological disorders (for example epilepsy, stroke, multiple sclerosis, or traumatic brain injury), implanted neuromodulation devices, unstable severe psychiatric conditions, or those unable/unwilling to self‑administer home stimulation or attend visits are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, double‑blind, sham‑controlled feasibility trial will enroll about 40 adults with chronic TMD to try daily transcutaneous auricular neurostimulation (tAN) at home. Participants will be randomly assigned to active or sham stimulation and will self‑administer mild electrical pulses to the auricular branch of the vagus nerve while researchers monitor adherence and retention. The study will track changes in pain intensity, cognitive flexibility, and mood using validated questionnaires and wearable smartwatch data. Results are intended to inform whether a larger clinical trial is warranted and whether tAN could be a practical non‑pharmacologic option for people who have not responded to standard TMD treatments.

Why it matters

Potential benefit: If successful, this approach could offer a noninvasive, drug‑free way to lower chronic orofacial pain and improve related mood and cognitive symptoms for people with TMD.

How similar studies have gone: Early small studies of noninvasive auricular vagus stimulation have shown promising signals for pain and mood, but its use specifically for chronic TMD is still largely untested and requires larger trials.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 to 65 years.
* Diagnosis of temporomandibular disorder (TMD) based on the Diagnostic Criteria for Temporomandibular Disorders (DC-TMD).
* Pain intensity of at least 4/10 on the Numeric Rating Scale (NRS) over the past two weeks.
* Chronic pain duration of at least three months, consistent with diagnosis of chronic TMD.
* Willingness to self-administer transcutaneous auricular nerve stimulation (tAN) at home and comply with study procedures.
* Fluency in English to ensure comprehension of study materials and assessments.
* Access to a smartphone or computer with internet to complete electronic study surveys and check-ins with the research team.

Exclusion Criteria:

* Neurological conditions that may interfere with study outcomes, including epilepsy, stroke, multiple sclerosis, or traumatic brain injury.
* Use of implanted neuromodulation devices, such as vagus nerve stimulators, deep brain stimulators, or cochlear implants.
* Unstable or severe psychiatric disorders, including active psychosis or severe depression with suicidal ideation.
* Pregnancy or intention to become pregnant during the study period.
* Skin conditions or other contraindications that prevent safe electrode placement on the auricular region (e.g., metal in the cymba concha that is unable or not willing to remove).
* History of trauma (e.g., skull fracture) or periauricular surgery (e.g., temporomandibular joint replacement, acoustic neuroma removal) which would affect the location and function of the target peripheral innervation.
* Use of both surgical and non-surgical bone conduction hearing devices.

Where it's running

  • University of Minnesota
    Minneapolis, Minnesota, United States
    Recruiting

Study contacts

  • Principal investigator: Donald Nixdorf, MD — University of Minnesota
  • Study coordinator: Carla Campbell
  • Email: ohcrc@umn.edu
  • Phone: 612-625-6976

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.